Speckle-type POZ (pox virus and zinc finger protein) protein gene deletion in ovarian cancer: Fluorescence in situ hybridization analysis of a tissue microarray

被引:11
|
作者
Hu, Xiaoyu [1 ]
Yang, Zhu [1 ]
Zeng, Manman [1 ]
Liu, Yi [1 ]
Yang, Xiaotao [1 ]
Li, Yanan [2 ]
Li, Xu [2 ]
Yu, Qiubo [2 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Gynecol, 76 Linjiang Rd, Chongqing 400010, Peoples R China
[2] Chongqing Med Univ, Mol Med Lab, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China
基金
中国国家自然科学基金;
关键词
ovarian cancer; speckle-type pox virus and zinc finger protein; tissue microarray; fluorescence in situ hybridization; FISH ANALYSIS; NUMERICAL ABNORMALITIES; PROSTATE-CANCER; P16; CDKN2; SPOP; TUMORS; AMPLIFICATION; CHROMOSOME-9; MUTATIONS;
D O I
10.3892/ol.2016.4643
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to investigate the status of speckle-type POZ (pox virus and zinc finger protein) protein (SPOP) gene located on chromosome 17q21 in ovarian cancer (OC). The present study evaluated a tissue microarray, which contained 90 samples of ovarian cancer and 10 samples of normal ovarian tissue, using fluorescence in situ hybridization (FISH). FISH is a method where a SPOP-specific DNA red fluorescence probe was used for the experimental group and a centromere-specific DNA green fluorescence probe for chromosome 17 was used for the control group. The present study demonstrated that a deletion of the SPOP gene was observed in 52.27% (46/88) of the ovarian cancer tissues, but was not identified in normal ovarian tissues. Simultaneously, monosomy 17 was frequently identified in the ovarian cancer tissues, but not in the normal ovarian tissues. Furthermore, the present data revealed that the ovarian cancer histological subtype and grade were significantly associated with a deletion of the SPOP gene, which was assessed by the appearance of monosomy 17 in the ovarian cancer samples; the deletion of the SPOP gene was observed in a large proportion of serous epithelial ovarian cancer (41/61; 67.21%), particularly in grade 3 (31/37; 83.78%). In conclusion, deletion of the SPOP gene on chromosome 17 in ovarian cancer samples, which results from monosomy 17, indicates that the SPOP gene may serve as a tumor suppressor gene in ovarian cancer.
引用
收藏
页码:658 / 662
页数:5
相关论文
共 9 条
  • [1] The molecular consequences of the novel speckle-type POZ protein (SPOP) gene mutations at the protein level: A prostate cancer perspective
    Eryilmaz, Isil Ezgi
    Vuruskan, Berna Aytac
    Kaygisiz, Onur
    Cecener, Gulsah
    Egeli, Unal
    Vuruskan, Hakan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 429 - 429
  • [2] Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations
    Pascal, Laura E.
    Wang, Zhou
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (04) : 594 - 595
  • [3] The association of speckle-type POZ protein with lymph node metastasis and prognosis in cancer patients A meta-analysis
    Cheng, Fei
    Zeng, Chunyan
    Zeng, Ling
    Wu, Chayan
    Chen, Youxiang
    MEDICINE, 2019, 98 (40)
  • [4] Immunohistochemical Analysis of Speckle-Type POZ Protein (SPOP) in Prostate Cancer, High Grade Prostatic Intraepithelial Neoplasia and Benign Glands
    Razmaria, A.
    Cohn, J.
    White, K.
    VanderGriend, D.
    Paner, G. P.
    LABORATORY INVESTIGATION, 2013, 93 : 243A - 243A
  • [5] Immunohistochemical Analysis of Speckle-Type POZ Protein (SPOP) in Prostate Cancer, High Grade Prostatic Intraepithelial Neoplasia and Benign Glands
    Razmaria, A.
    Cohn, J.
    White, K.
    VanderGriend, D.
    Paner, G. P.
    MODERN PATHOLOGY, 2013, 26 : 243A - 243A
  • [6] Amplification and protein expression of androgen receptor gene in prostate cancer cells: Fluorescence in situ hybridization analysis
    Zhang, Xian
    Hong, Shi-Zhe
    Lin, Er-Jiang
    Wang, Da-Ya
    Li, Zhi-Jia
    Chen, Li
    ONCOLOGY LETTERS, 2015, 9 (06) : 2617 - 2622
  • [7] HER-2/neu protein expression and gene amplification in breast cancer: immunohistochemistry and chromogenic in situ hybridization study using tissue microarray
    Hazim, Ammar Imad
    Kaur, Gurjeet
    HEALTHMED, 2011, 5 (05): : 1065 - 1071
  • [8] HER2/CHR 17 tissue microarray chromogenic in situ hybridization analysis in colon adenocarcinoma: multiple gene signals vs protein expression
    Fotiades, Panagiotis P.
    Tsiambas, Evangelos
    Lazaris, Andreas C.
    Saetta, Angeliki A.
    Karameris, Andreas
    Vilaras, George
    Patsouris, Efstratios
    JOURNAL OF BUON, 2014, 19 (01): : 109 - 114
  • [9] HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer:: A study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization
    Tan, DF
    Deeb, G
    Wang, JM
    Slocum, HK
    Winston, J
    Wiseman, S
    Beck, A
    Sait, S
    Anderson, T
    Nwogu, C
    Ramnath, N
    Loewen, G
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2003, 12 (04) : 201 - 211